Japan has long been implementing policies to raise the volume share of generic drugs to help control rising healthcare costs. From 1 October, the country has newly started to charge extra for non-generic pharmaceutical products, excluding biopharma drugs, under several conditions.
When receiving a prescribed drug, if a patient insists on a non-generic option without any specific medical reasons from the...